Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Clin Microbiol Infect. 2016 Feb 3;22(6):513–519. doi: 10.1016/j.cmi.2016.01.023

Table 1. Demographics.

All data expressed as n (%), unless otherwise indicated. IQR, interquartile range.

Controls BSI p# pneumonia p# UTI p#
n 223 90 - 49 - 121 -
Age, median (IQR) 71 (63–81) 63 (54–78) <0.01 68 (58–81) 0.36 69 (57–82) 0.20
Female 148 (66) 44 (48) <0.01 24 (49) 0.03 65 (54) 0.03
Race/Ethnicity 0.06 0.53 0.05
 White 132 (59) 45 (50) 27 (55) 58 (48)
 Black 78 (35) 44 (49) 17 (35) 58 (48)
 Hispanic 5 (2) 0 3 (6) 4 (3)
 Other 8 (4) 1 (1) 2 (4) 1 (1)
Charlson comorbidity index, median (IQR) 3 (2–5) 3 (2–5) 0.51 3 (2–5) 0.18 3 (2–5) 0.43
Diabetes mellitus 117 (52) 40 (44) 0.21 24 (49) 0.75 60 (50) 0.65
Renal failure 55 (25) 31 (34) 0.09 9 (18) 0.45 30 (25) 1.0
Heart disease 125 (56) 41 (46) 0.13 31 (63) 0.43 57 (47) 0.12
COPD 63 (29) 19 (21) 0.20 18 (37) 0.30 34 (28) 1.0
Malignancy 42 (19) 21 (23) 0.44 4 (8) 0.09 18 (15) 0.38
#

comparison with controls.

renal failure defined as creatinine >2 mg/dL upon admission.

HHS Vulnerability Disclosure